These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 24652622)

  • 1. Label-free cell-based dynamic mass redistribution assays.
    Gitschier HJ; Bergeron AB; Randle DH
    Curr Protoc Chem Biol; 2014 Mar; 6(1):39-51. PubMed ID: 24652622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of dynamic mass redistribution technology for pharmacological studies of recombinant and endogenously expressed g protein-coupled receptors.
    Lee PH; Gao A; van Staden C; Ly J; Salon J; Xu A; Fang Y; Verkleeren R
    Assay Drug Dev Technol; 2008 Feb; 6(1):83-94. PubMed ID: 18336088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applying label-free dynamic mass redistribution assay for studying endogenous FPR1 receptor signalling in human neutrophils.
    Christensen HB; Gloriam DE; Pedersen DS; Cowland JB; Borregaard N; Bräuner-Osborne H
    J Pharmacol Toxicol Methods; 2017 Nov; 88(Pt 1):72-78. PubMed ID: 28716665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Label-Free Dynamic Mass Redistribution and Bio-Impedance Methods for Drug Discovery.
    Grundmann M
    Curr Protoc Pharmacol; 2017 Jun; 77():9.24.1-9.24.21. PubMed ID: 28640952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Label-free drug screening assay multiplexed with an orthogonal time-resolved fluorescence labeled assay.
    Kiss L; Cselenyák A; Visegrády A
    Anal Biochem; 2019 Feb; 566():126-132. PubMed ID: 30452893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing label-free biosensors for pharmacological screening with cell-based functional assays.
    Peters MF; Vaillancourt F; Heroux M; Valiquette M; Scott CW
    Assay Drug Dev Technol; 2010 Apr; 8(2):219-27. PubMed ID: 20085460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced selectivity screening of GPCR ligands using a label-free cell based assay technology.
    McGuinness RP; Proctor JM; Gallant DL; van Staden CJ; Ly JT; Tang FL; Lee PH
    Comb Chem High Throughput Screen; 2009 Sep; 12(8):812-23. PubMed ID: 19531008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Label-free impedance-based whole cell assay to study GPCR pharmacology.
    Doornbos MLJ; Heitman LH
    Methods Cell Biol; 2019; 149():179-194. PubMed ID: 30616818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Label-free optical biosensor: a tool for G protein-coupled receptors pharmacology profiling and inverse agonists identification.
    Lee PH
    J Recept Signal Transduct Res; 2009; 29(3-4):146-53. PubMed ID: 19594401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deconvolution of complex G protein-coupled receptor signaling in live cells using dynamic mass redistribution measurements.
    Schröder R; Janssen N; Schmidt J; Kebig A; Merten N; Hennen S; Müller A; Blättermann S; Mohr-Andrä M; Zahn S; Wenzel J; Smith NJ; Gomeza J; Drewke C; Milligan G; Mohr K; Kostenis E
    Nat Biotechnol; 2010 Sep; 28(9):943-9. PubMed ID: 20711173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-invasive optical biosensor for assaying endogenous G protein-coupled receptors in adherent cells.
    Fang Y; Li G; Ferrie AM
    J Pharmacol Toxicol Methods; 2007; 55(3):314-22. PubMed ID: 17207642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating cellular impedance assays for detection of GPCR pleiotropic signaling and functional selectivity.
    Peters MF; Scott CW
    J Biomol Screen; 2009 Mar; 14(3):246-55. PubMed ID: 19211780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meeting review: a summary of the Label-Free Summit.
    Verkleeren R; Marala R
    J Recept Signal Transduct Res; 2009; 29(3-4):128-31. PubMed ID: 19640219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological profile of the neuropeptide S receptor: Dynamic mass redistribution studies.
    Ruzza C; Ferrari F; Guerrini R; Marzola E; Preti D; Reinscheid RK; Calo G
    Pharmacol Res Perspect; 2018 Dec; 6(6):e00445. PubMed ID: 30534379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Label-free optical biosensor for probing integrative role of adenylyl cyclase in G protein-coupled receptor signaling.
    Tran E; Fang Y
    J Recept Signal Transduct Res; 2009; 29(3-4):154-62. PubMed ID: 19604131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Label-free cell-based assays for GPCR screening.
    Fang Y; Frutos AG; Verklereen R
    Comb Chem High Throughput Screen; 2008 Jun; 11(5):357-69. PubMed ID: 18537557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic mass redistribution as a means to measure and differentiate signaling via opioid and cannabinoid receptors.
    Codd EE; Mabus JR; Murray BS; Zhang SP; Flores CM
    Assay Drug Dev Technol; 2011 Aug; 9(4):362-72. PubMed ID: 21323580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applying label-free dynamic mass redistribution technology to frame signaling of G protein-coupled receptors noninvasively in living cells.
    Schröder R; Schmidt J; Blättermann S; Peters L; Janssen N; Grundmann M; Seemann W; Kaufel D; Merten N; Drewke C; Gomeza J; Milligan G; Mohr K; Kostenis E
    Nat Protoc; 2011 Oct; 6(11):1748-60. PubMed ID: 22015845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An optical dynamic mass redistribution assay reveals biased signaling of dualsteric GPCR activators.
    Kebig A; Kostenis E; Mohr K; Mohr-Andrä M
    J Recept Signal Transduct Res; 2009; 29(3-4):140-5. PubMed ID: 19586284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a label-free assay for sodium-dependent phosphate transporter NaPi-IIb.
    Wong SH; Gao A; Ward S; Henley C; Lee PH
    J Biomol Screen; 2012 Jul; 17(6):829-34. PubMed ID: 22496097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.